Imaging is an essential non-invasive tool for building disease understanding and characterization. Contrast agents or targeted imaging (molecular imaging) allow specific features to be delineated, such as vascularization, abnormal metabolism, or disease-specific biomarkers. GE Research has an active program developing molecular imaging agents that benefits from our strong capabilities in diagnostic imaging hardware and histopathogical technology for characterization of biomarkers in diseased tissue.
Cancer cell biology is highly complex, comprising multiple cell types in different metabolic states, and is spatially heterogeneous. Over the last 10 years, our GE Research multi-disciplinary team has developed a multiplexed imaging and cell level analytics technology that allows analysis of up to 60 protein biomarkers in every cell in a 5 um FFPE tissue section (Cell DIVE™).
